Global Blood Irradiation
Global Blood Irradiation

Blood Irradiation Comprehensive Study by Type (X-ray Blood Irradiation, Gamma-ray Blood Irradiation), Application (Patients Inherited Immune System Disorder, Patients with Hodgkin’s Disease, Others), End User (Blood Bank, Hospital, Research Institutions) Players and Region - Global Market Outlook to 2025

Blood Irradiation Market Segmented into XX Submarkets. | Forecast Years: 2020- 2025  

Apr 2020 Edition 203 Pages 200 Tables & Figures
  • Summary
  • Market Segments
  • Table of Content
  • List of Tables & Figures
  • Companies Mentioned
Scope of the Study

The global Blood Irradiation market is expected to witness high demand in the forecasted period due to the rising number of Blood irritation patients. Irradiated blood is the blood that has been treated with radiation (by x-rays or other forms of radioactivity) to prevent TransfusionAssociated Graft-versus-Host Disease (TA-GvHD). TA-GvHD is a rare but serious complication of blood transfusion caused by white blood cells called lymphocytes in the transfused blood. Even a very small number of these cells may recognize the patient receiving the blood as ‘different’ and cause severe illness or even death.

The market study is being classified by Type (X-ray Blood Irradiation and Gamma-ray Blood Irradiation), by Application (Patients Inherited Immune System Disorder, Patients with Hodgkin’s Disease and Others) and major geographies with country level break-up.

Wuhan HNC Technology Co., Ltd. (China), O3Vets (United States), STS Steuerungstechnik + Strahlenchutz GmbH (Germany), Best Theratronics (Canada), Hitachi (Japan), Gilardoni (Italy), Gamma-Service Recycling GmbH (Germany), Cegelec (France), Rad Source Technologies (United States) and JL SHEPHERD & ASSOCIATES (United States) are some of the key players profiled in the study. Additionally, the Players which are also part of the research are Shinva Medical (China) and NPIC (United States).

The companies are exploring the market by adopting expansions, investments, new service launches and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions across the globe to avail a competitive advantage through combined collaborations. Research Analyst at AMA predicts that United States Players will contribute to the maximum growth of Global Blood Irradiation market throughout the predicted period.

Segment Analysis
AdvanceMarketAnalytics has segmented the market of Global Blood Irradiation market by Type, Application and Region.

On the basis of geography, the market of Blood Irradiation has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). North America region held largest market share in the year 2019. Europe on the other hand stood as second largest market due to the presence of key companies into the region and high technological advancement. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

Market Drivers
  • The Rising Number of Blood-Related Diseases across the Globe

Market Trend
  • Increasing Prevalence of Inherited Immune System Disorder
  • High Demand for Patients with Hodgkin’s Disease

Restraints
  • The High Cost Associated with Blood Irradiation
  • The Risk Related to the Gamma-ray Blood Irradiation

Opportunities
  • Rising Healthcare Expenditure in Developing and Developed Countries
  • Growing Technological Advancement

Challenges
  • Stringent Government Regulation Related to Device Used for Blood Irradiation



"The US NRC requires increased security measures to reduce the risk of unauthorized use of radioactive materials for gamma irradiators. The US Office of Radiological Security (ORS) offers federally funded security enhancements for radioisotope-based blood irradiators that are above and beyond the NRC’s Part 37 requirements – see Additional Resources section."

Key Target Audience
Blood Irradiation Providers, Government Regulatory Bodies, Private Research Organizations, Government Research Organizations and Others

Customization in the Report Available:
The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**
** Confirmation on availability of data would be informed prior purchase
Report Objectives / Segmentation Covered
By Type
  • X-ray Blood Irradiation
  • Gamma-ray Blood Irradiation
By Application
  • Patients Inherited Immune System Disorder
  • Patients with Hodgkin’s Disease
  • Others
By End User
  • Blood Bank
  • Hospital
  • Research Institutions

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. The Rising Number of Blood-Related Diseases across the Globe
    • 3.3. Market Challenges
      • 3.3.1. Stringent Government Regulation Related to Device Used for Blood Irradiation
    • 3.4. Market Trends
      • 3.4.1. Increasing Prevalence of Inherited Immune System Disorder
      • 3.4.2. High Demand for Patients with Hodgkin’s Disease
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Blood Irradiation, by Type, Application, End User and Region (value and price ) (2014-2019)
    • 5.1. Introduction
    • 5.2. Global Blood Irradiation (Value)
      • 5.2.1. Global Blood Irradiation by: Type (Value)
        • 5.2.1.1. X-ray Blood Irradiation
        • 5.2.1.2. Gamma-ray Blood Irradiation
      • 5.2.2. Global Blood Irradiation by: Application (Value)
        • 5.2.2.1. Patients Inherited Immune System Disorder
        • 5.2.2.2. Patients with Hodgkin’s Disease
        • 5.2.2.3. Others
      • 5.2.3. Global Blood Irradiation by: End User (Value)
        • 5.2.3.1. Blood Bank
        • 5.2.3.2. Hospital
        • 5.2.3.3. Research Institutions
      • 5.2.4. Global Blood Irradiation Region
        • 5.2.4.1. South America
          • 5.2.4.1.1. Brazil
          • 5.2.4.1.2. Argentina
          • 5.2.4.1.3. Rest of South America
        • 5.2.4.2. Asia Pacific
          • 5.2.4.2.1. China
          • 5.2.4.2.2. Japan
          • 5.2.4.2.3. India
          • 5.2.4.2.4. South Korea
          • 5.2.4.2.5. Taiwan
          • 5.2.4.2.6. Australia
          • 5.2.4.2.7. Rest of Asia-Pacific
        • 5.2.4.3. Europe
          • 5.2.4.3.1. Germany
          • 5.2.4.3.2. France
          • 5.2.4.3.3. Italy
          • 5.2.4.3.4. United Kingdom
          • 5.2.4.3.5. Netherlands
          • 5.2.4.3.6. Rest of Europe
        • 5.2.4.4. MEA
          • 5.2.4.4.1. Middle East
          • 5.2.4.4.2. Africa
        • 5.2.4.5. North America
          • 5.2.4.5.1. United States
          • 5.2.4.5.2. Canada
          • 5.2.4.5.3. Mexico
    • 5.3. Global Blood Irradiation (Price)
      • 5.3.1. Global Blood Irradiation by: Type (Price)
  • 6. Blood Irradiation: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2019)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Wuhan HNC Technology Co., Ltd. (China)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. O3Vets (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. STS Steuerungstechnik + Strahlenchutz GmbH (Germany)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Best Theratronics (Canada)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Hitachi (Japan)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Gilardoni (Italy)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Gamma-Service Recycling GmbH (Germany)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Cegelec (France)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Rad Source Technologies (United States)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. JL SHEPHERD & ASSOCIATES (United States)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Blood Irradiation Sale, by Type, Application, End User and Region (value and price ) (2020-2025)
    • 7.1. Introduction
    • 7.2. Global Blood Irradiation (Value)
      • 7.2.1. Global Blood Irradiation by: Type (Value)
        • 7.2.1.1. X-ray Blood Irradiation
        • 7.2.1.2. Gamma-ray Blood Irradiation
      • 7.2.2. Global Blood Irradiation by: Application (Value)
        • 7.2.2.1. Patients Inherited Immune System Disorder
        • 7.2.2.2. Patients with Hodgkin’s Disease
        • 7.2.2.3. Others
      • 7.2.3. Global Blood Irradiation by: End User (Value)
        • 7.2.3.1. Blood Bank
        • 7.2.3.2. Hospital
        • 7.2.3.3. Research Institutions
      • 7.2.4. Global Blood Irradiation Region
        • 7.2.4.1. South America
          • 7.2.4.1.1. Brazil
          • 7.2.4.1.2. Argentina
          • 7.2.4.1.3. Rest of South America
        • 7.2.4.2. Asia Pacific
          • 7.2.4.2.1. China
          • 7.2.4.2.2. Japan
          • 7.2.4.2.3. India
          • 7.2.4.2.4. South Korea
          • 7.2.4.2.5. Taiwan
          • 7.2.4.2.6. Australia
          • 7.2.4.2.7. Rest of Asia-Pacific
        • 7.2.4.3. Europe
          • 7.2.4.3.1. Germany
          • 7.2.4.3.2. France
          • 7.2.4.3.3. Italy
          • 7.2.4.3.4. United Kingdom
          • 7.2.4.3.5. Netherlands
          • 7.2.4.3.6. Rest of Europe
        • 7.2.4.4. MEA
          • 7.2.4.4.1. Middle East
          • 7.2.4.4.2. Africa
        • 7.2.4.5. North America
          • 7.2.4.5.1. United States
          • 7.2.4.5.2. Canada
          • 7.2.4.5.3. Mexico
    • 7.3. Global Blood Irradiation (Price)
      • 7.3.1. Global Blood Irradiation by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Blood Irradiation: by Type(USD Million)
  • Table 2. Blood Irradiation X-ray Blood Irradiation , by Region USD Million (2014-2019)
  • Table 3. Blood Irradiation Gamma-ray Blood Irradiation , by Region USD Million (2014-2019)
  • Table 4. Blood Irradiation: by Application(USD Million)
  • Table 5. Blood Irradiation Patients Inherited Immune System Disorder , by Region USD Million (2014-2019)
  • Table 6. Blood Irradiation Patients with Hodgkin’s Disease , by Region USD Million (2014-2019)
  • Table 7. Blood Irradiation Others , by Region USD Million (2014-2019)
  • Table 8. Blood Irradiation: by End User(USD Million)
  • Table 9. Blood Irradiation Blood Bank , by Region USD Million (2014-2019)
  • Table 10. Blood Irradiation Hospital , by Region USD Million (2014-2019)
  • Table 11. Blood Irradiation Research Institutions , by Region USD Million (2014-2019)
  • Table 12. South America Blood Irradiation, by Country USD Million (2014-2019)
  • Table 13. South America Blood Irradiation, by Type USD Million (2014-2019)
  • Table 14. South America Blood Irradiation, by Application USD Million (2014-2019)
  • Table 15. South America Blood Irradiation, by End User USD Million (2014-2019)
  • Table 16. Brazil Blood Irradiation, by Type USD Million (2014-2019)
  • Table 17. Brazil Blood Irradiation, by Application USD Million (2014-2019)
  • Table 18. Brazil Blood Irradiation, by End User USD Million (2014-2019)
  • Table 19. Argentina Blood Irradiation, by Type USD Million (2014-2019)
  • Table 20. Argentina Blood Irradiation, by Application USD Million (2014-2019)
  • Table 21. Argentina Blood Irradiation, by End User USD Million (2014-2019)
  • Table 22. Rest of South America Blood Irradiation, by Type USD Million (2014-2019)
  • Table 23. Rest of South America Blood Irradiation, by Application USD Million (2014-2019)
  • Table 24. Rest of South America Blood Irradiation, by End User USD Million (2014-2019)
  • Table 25. Asia Pacific Blood Irradiation, by Country USD Million (2014-2019)
  • Table 26. Asia Pacific Blood Irradiation, by Type USD Million (2014-2019)
  • Table 27. Asia Pacific Blood Irradiation, by Application USD Million (2014-2019)
  • Table 28. Asia Pacific Blood Irradiation, by End User USD Million (2014-2019)
  • Table 29. China Blood Irradiation, by Type USD Million (2014-2019)
  • Table 30. China Blood Irradiation, by Application USD Million (2014-2019)
  • Table 31. China Blood Irradiation, by End User USD Million (2014-2019)
  • Table 32. Japan Blood Irradiation, by Type USD Million (2014-2019)
  • Table 33. Japan Blood Irradiation, by Application USD Million (2014-2019)
  • Table 34. Japan Blood Irradiation, by End User USD Million (2014-2019)
  • Table 35. India Blood Irradiation, by Type USD Million (2014-2019)
  • Table 36. India Blood Irradiation, by Application USD Million (2014-2019)
  • Table 37. India Blood Irradiation, by End User USD Million (2014-2019)
  • Table 38. South Korea Blood Irradiation, by Type USD Million (2014-2019)
  • Table 39. South Korea Blood Irradiation, by Application USD Million (2014-2019)
  • Table 40. South Korea Blood Irradiation, by End User USD Million (2014-2019)
  • Table 41. Taiwan Blood Irradiation, by Type USD Million (2014-2019)
  • Table 42. Taiwan Blood Irradiation, by Application USD Million (2014-2019)
  • Table 43. Taiwan Blood Irradiation, by End User USD Million (2014-2019)
  • Table 44. Australia Blood Irradiation, by Type USD Million (2014-2019)
  • Table 45. Australia Blood Irradiation, by Application USD Million (2014-2019)
  • Table 46. Australia Blood Irradiation, by End User USD Million (2014-2019)
  • Table 47. Rest of Asia-Pacific Blood Irradiation, by Type USD Million (2014-2019)
  • Table 48. Rest of Asia-Pacific Blood Irradiation, by Application USD Million (2014-2019)
  • Table 49. Rest of Asia-Pacific Blood Irradiation, by End User USD Million (2014-2019)
  • Table 50. Europe Blood Irradiation, by Country USD Million (2014-2019)
  • Table 51. Europe Blood Irradiation, by Type USD Million (2014-2019)
  • Table 52. Europe Blood Irradiation, by Application USD Million (2014-2019)
  • Table 53. Europe Blood Irradiation, by End User USD Million (2014-2019)
  • Table 54. Germany Blood Irradiation, by Type USD Million (2014-2019)
  • Table 55. Germany Blood Irradiation, by Application USD Million (2014-2019)
  • Table 56. Germany Blood Irradiation, by End User USD Million (2014-2019)
  • Table 57. France Blood Irradiation, by Type USD Million (2014-2019)
  • Table 58. France Blood Irradiation, by Application USD Million (2014-2019)
  • Table 59. France Blood Irradiation, by End User USD Million (2014-2019)
  • Table 60. Italy Blood Irradiation, by Type USD Million (2014-2019)
  • Table 61. Italy Blood Irradiation, by Application USD Million (2014-2019)
  • Table 62. Italy Blood Irradiation, by End User USD Million (2014-2019)
  • Table 63. United Kingdom Blood Irradiation, by Type USD Million (2014-2019)
  • Table 64. United Kingdom Blood Irradiation, by Application USD Million (2014-2019)
  • Table 65. United Kingdom Blood Irradiation, by End User USD Million (2014-2019)
  • Table 66. Netherlands Blood Irradiation, by Type USD Million (2014-2019)
  • Table 67. Netherlands Blood Irradiation, by Application USD Million (2014-2019)
  • Table 68. Netherlands Blood Irradiation, by End User USD Million (2014-2019)
  • Table 69. Rest of Europe Blood Irradiation, by Type USD Million (2014-2019)
  • Table 70. Rest of Europe Blood Irradiation, by Application USD Million (2014-2019)
  • Table 71. Rest of Europe Blood Irradiation, by End User USD Million (2014-2019)
  • Table 72. MEA Blood Irradiation, by Country USD Million (2014-2019)
  • Table 73. MEA Blood Irradiation, by Type USD Million (2014-2019)
  • Table 74. MEA Blood Irradiation, by Application USD Million (2014-2019)
  • Table 75. MEA Blood Irradiation, by End User USD Million (2014-2019)
  • Table 76. Middle East Blood Irradiation, by Type USD Million (2014-2019)
  • Table 77. Middle East Blood Irradiation, by Application USD Million (2014-2019)
  • Table 78. Middle East Blood Irradiation, by End User USD Million (2014-2019)
  • Table 79. Africa Blood Irradiation, by Type USD Million (2014-2019)
  • Table 80. Africa Blood Irradiation, by Application USD Million (2014-2019)
  • Table 81. Africa Blood Irradiation, by End User USD Million (2014-2019)
  • Table 82. North America Blood Irradiation, by Country USD Million (2014-2019)
  • Table 83. North America Blood Irradiation, by Type USD Million (2014-2019)
  • Table 84. North America Blood Irradiation, by Application USD Million (2014-2019)
  • Table 85. North America Blood Irradiation, by End User USD Million (2014-2019)
  • Table 86. United States Blood Irradiation, by Type USD Million (2014-2019)
  • Table 87. United States Blood Irradiation, by Application USD Million (2014-2019)
  • Table 88. United States Blood Irradiation, by End User USD Million (2014-2019)
  • Table 89. Canada Blood Irradiation, by Type USD Million (2014-2019)
  • Table 90. Canada Blood Irradiation, by Application USD Million (2014-2019)
  • Table 91. Canada Blood Irradiation, by End User USD Million (2014-2019)
  • Table 92. Mexico Blood Irradiation, by Type USD Million (2014-2019)
  • Table 93. Mexico Blood Irradiation, by Application USD Million (2014-2019)
  • Table 94. Mexico Blood Irradiation, by End User USD Million (2014-2019)
  • Table 95. Blood Irradiation: by Type(USD/Units)
  • Table 96. Company Basic Information, Sales Area and Its Competitors
  • Table 97. Company Basic Information, Sales Area and Its Competitors
  • Table 98. Company Basic Information, Sales Area and Its Competitors
  • Table 99. Company Basic Information, Sales Area and Its Competitors
  • Table 100. Company Basic Information, Sales Area and Its Competitors
  • Table 101. Company Basic Information, Sales Area and Its Competitors
  • Table 102. Company Basic Information, Sales Area and Its Competitors
  • Table 103. Company Basic Information, Sales Area and Its Competitors
  • Table 104. Company Basic Information, Sales Area and Its Competitors
  • Table 105. Company Basic Information, Sales Area and Its Competitors
  • Table 106. Blood Irradiation: by Type(USD Million)
  • Table 107. Blood Irradiation X-ray Blood Irradiation , by Region USD Million (2020-2025)
  • Table 108. Blood Irradiation Gamma-ray Blood Irradiation , by Region USD Million (2020-2025)
  • Table 109. Blood Irradiation: by Application(USD Million)
  • Table 110. Blood Irradiation Patients Inherited Immune System Disorder , by Region USD Million (2020-2025)
  • Table 111. Blood Irradiation Patients with Hodgkin’s Disease , by Region USD Million (2020-2025)
  • Table 112. Blood Irradiation Others , by Region USD Million (2020-2025)
  • Table 113. Blood Irradiation: by End User(USD Million)
  • Table 114. Blood Irradiation Blood Bank , by Region USD Million (2020-2025)
  • Table 115. Blood Irradiation Hospital , by Region USD Million (2020-2025)
  • Table 116. Blood Irradiation Research Institutions , by Region USD Million (2020-2025)
  • Table 117. South America Blood Irradiation, by Country USD Million (2020-2025)
  • Table 118. South America Blood Irradiation, by Type USD Million (2020-2025)
  • Table 119. South America Blood Irradiation, by Application USD Million (2020-2025)
  • Table 120. South America Blood Irradiation, by End User USD Million (2020-2025)
  • Table 121. Brazil Blood Irradiation, by Type USD Million (2020-2025)
  • Table 122. Brazil Blood Irradiation, by Application USD Million (2020-2025)
  • Table 123. Brazil Blood Irradiation, by End User USD Million (2020-2025)
  • Table 124. Argentina Blood Irradiation, by Type USD Million (2020-2025)
  • Table 125. Argentina Blood Irradiation, by Application USD Million (2020-2025)
  • Table 126. Argentina Blood Irradiation, by End User USD Million (2020-2025)
  • Table 127. Rest of South America Blood Irradiation, by Type USD Million (2020-2025)
  • Table 128. Rest of South America Blood Irradiation, by Application USD Million (2020-2025)
  • Table 129. Rest of South America Blood Irradiation, by End User USD Million (2020-2025)
  • Table 130. Asia Pacific Blood Irradiation, by Country USD Million (2020-2025)
  • Table 131. Asia Pacific Blood Irradiation, by Type USD Million (2020-2025)
  • Table 132. Asia Pacific Blood Irradiation, by Application USD Million (2020-2025)
  • Table 133. Asia Pacific Blood Irradiation, by End User USD Million (2020-2025)
  • Table 134. China Blood Irradiation, by Type USD Million (2020-2025)
  • Table 135. China Blood Irradiation, by Application USD Million (2020-2025)
  • Table 136. China Blood Irradiation, by End User USD Million (2020-2025)
  • Table 137. Japan Blood Irradiation, by Type USD Million (2020-2025)
  • Table 138. Japan Blood Irradiation, by Application USD Million (2020-2025)
  • Table 139. Japan Blood Irradiation, by End User USD Million (2020-2025)
  • Table 140. India Blood Irradiation, by Type USD Million (2020-2025)
  • Table 141. India Blood Irradiation, by Application USD Million (2020-2025)
  • Table 142. India Blood Irradiation, by End User USD Million (2020-2025)
  • Table 143. South Korea Blood Irradiation, by Type USD Million (2020-2025)
  • Table 144. South Korea Blood Irradiation, by Application USD Million (2020-2025)
  • Table 145. South Korea Blood Irradiation, by End User USD Million (2020-2025)
  • Table 146. Taiwan Blood Irradiation, by Type USD Million (2020-2025)
  • Table 147. Taiwan Blood Irradiation, by Application USD Million (2020-2025)
  • Table 148. Taiwan Blood Irradiation, by End User USD Million (2020-2025)
  • Table 149. Australia Blood Irradiation, by Type USD Million (2020-2025)
  • Table 150. Australia Blood Irradiation, by Application USD Million (2020-2025)
  • Table 151. Australia Blood Irradiation, by End User USD Million (2020-2025)
  • Table 152. Rest of Asia-Pacific Blood Irradiation, by Type USD Million (2020-2025)
  • Table 153. Rest of Asia-Pacific Blood Irradiation, by Application USD Million (2020-2025)
  • Table 154. Rest of Asia-Pacific Blood Irradiation, by End User USD Million (2020-2025)
  • Table 155. Europe Blood Irradiation, by Country USD Million (2020-2025)
  • Table 156. Europe Blood Irradiation, by Type USD Million (2020-2025)
  • Table 157. Europe Blood Irradiation, by Application USD Million (2020-2025)
  • Table 158. Europe Blood Irradiation, by End User USD Million (2020-2025)
  • Table 159. Germany Blood Irradiation, by Type USD Million (2020-2025)
  • Table 160. Germany Blood Irradiation, by Application USD Million (2020-2025)
  • Table 161. Germany Blood Irradiation, by End User USD Million (2020-2025)
  • Table 162. France Blood Irradiation, by Type USD Million (2020-2025)
  • Table 163. France Blood Irradiation, by Application USD Million (2020-2025)
  • Table 164. France Blood Irradiation, by End User USD Million (2020-2025)
  • Table 165. Italy Blood Irradiation, by Type USD Million (2020-2025)
  • Table 166. Italy Blood Irradiation, by Application USD Million (2020-2025)
  • Table 167. Italy Blood Irradiation, by End User USD Million (2020-2025)
  • Table 168. United Kingdom Blood Irradiation, by Type USD Million (2020-2025)
  • Table 169. United Kingdom Blood Irradiation, by Application USD Million (2020-2025)
  • Table 170. United Kingdom Blood Irradiation, by End User USD Million (2020-2025)
  • Table 171. Netherlands Blood Irradiation, by Type USD Million (2020-2025)
  • Table 172. Netherlands Blood Irradiation, by Application USD Million (2020-2025)
  • Table 173. Netherlands Blood Irradiation, by End User USD Million (2020-2025)
  • Table 174. Rest of Europe Blood Irradiation, by Type USD Million (2020-2025)
  • Table 175. Rest of Europe Blood Irradiation, by Application USD Million (2020-2025)
  • Table 176. Rest of Europe Blood Irradiation, by End User USD Million (2020-2025)
  • Table 177. MEA Blood Irradiation, by Country USD Million (2020-2025)
  • Table 178. MEA Blood Irradiation, by Type USD Million (2020-2025)
  • Table 179. MEA Blood Irradiation, by Application USD Million (2020-2025)
  • Table 180. MEA Blood Irradiation, by End User USD Million (2020-2025)
  • Table 181. Middle East Blood Irradiation, by Type USD Million (2020-2025)
  • Table 182. Middle East Blood Irradiation, by Application USD Million (2020-2025)
  • Table 183. Middle East Blood Irradiation, by End User USD Million (2020-2025)
  • Table 184. Africa Blood Irradiation, by Type USD Million (2020-2025)
  • Table 185. Africa Blood Irradiation, by Application USD Million (2020-2025)
  • Table 186. Africa Blood Irradiation, by End User USD Million (2020-2025)
  • Table 187. North America Blood Irradiation, by Country USD Million (2020-2025)
  • Table 188. North America Blood Irradiation, by Type USD Million (2020-2025)
  • Table 189. North America Blood Irradiation, by Application USD Million (2020-2025)
  • Table 190. North America Blood Irradiation, by End User USD Million (2020-2025)
  • Table 191. United States Blood Irradiation, by Type USD Million (2020-2025)
  • Table 192. United States Blood Irradiation, by Application USD Million (2020-2025)
  • Table 193. United States Blood Irradiation, by End User USD Million (2020-2025)
  • Table 194. Canada Blood Irradiation, by Type USD Million (2020-2025)
  • Table 195. Canada Blood Irradiation, by Application USD Million (2020-2025)
  • Table 196. Canada Blood Irradiation, by End User USD Million (2020-2025)
  • Table 197. Mexico Blood Irradiation, by Type USD Million (2020-2025)
  • Table 198. Mexico Blood Irradiation, by Application USD Million (2020-2025)
  • Table 199. Mexico Blood Irradiation, by End User USD Million (2020-2025)
  • Table 200. Blood Irradiation: by Type(USD/Units)
  • Table 201. Research Programs/Design for This Report
  • Table 202. Key Data Information from Secondary Sources
  • Table 203. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Blood Irradiation: by Type USD Million (2014-2019)
  • Figure 5. Global Blood Irradiation: by Application USD Million (2014-2019)
  • Figure 6. Global Blood Irradiation: by End User USD Million (2014-2019)
  • Figure 7. South America Blood Irradiation Share (%), by Country
  • Figure 8. Asia Pacific Blood Irradiation Share (%), by Country
  • Figure 9. Europe Blood Irradiation Share (%), by Country
  • Figure 10. MEA Blood Irradiation Share (%), by Country
  • Figure 11. North America Blood Irradiation Share (%), by Country
  • Figure 12. Global Blood Irradiation: by Type USD/Units (2014-2019)
  • Figure 13. Global Blood Irradiation share by Players 2019 (%)
  • Figure 14. Global Blood Irradiation share by Players (Top 3) 2019(%)
  • Figure 15. Global Blood Irradiation share by Players (Top 5) 2019(%)
  • Figure 16. BCG Matrix for key Companies
  • Figure 17. Wuhan HNC Technology Co., Ltd. (China) Revenue, Net Income and Gross profit
  • Figure 18. Wuhan HNC Technology Co., Ltd. (China) Revenue: by Geography 2019
  • Figure 19. O3Vets (United States) Revenue, Net Income and Gross profit
  • Figure 20. O3Vets (United States) Revenue: by Geography 2019
  • Figure 21. STS Steuerungstechnik + Strahlenchutz GmbH (Germany) Revenue, Net Income and Gross profit
  • Figure 22. STS Steuerungstechnik + Strahlenchutz GmbH (Germany) Revenue: by Geography 2019
  • Figure 23. Best Theratronics (Canada) Revenue, Net Income and Gross profit
  • Figure 24. Best Theratronics (Canada) Revenue: by Geography 2019
  • Figure 25. Hitachi (Japan) Revenue, Net Income and Gross profit
  • Figure 26. Hitachi (Japan) Revenue: by Geography 2019
  • Figure 27. Gilardoni (Italy) Revenue, Net Income and Gross profit
  • Figure 28. Gilardoni (Italy) Revenue: by Geography 2019
  • Figure 29. Gamma-Service Recycling GmbH (Germany) Revenue, Net Income and Gross profit
  • Figure 30. Gamma-Service Recycling GmbH (Germany) Revenue: by Geography 2019
  • Figure 31. Cegelec (France) Revenue, Net Income and Gross profit
  • Figure 32. Cegelec (France) Revenue: by Geography 2019
  • Figure 33. Rad Source Technologies (United States) Revenue, Net Income and Gross profit
  • Figure 34. Rad Source Technologies (United States) Revenue: by Geography 2019
  • Figure 35. JL SHEPHERD & ASSOCIATES (United States) Revenue, Net Income and Gross profit
  • Figure 36. JL SHEPHERD & ASSOCIATES (United States) Revenue: by Geography 2019
  • Figure 37. Global Blood Irradiation: by Type USD Million (2020-2025)
  • Figure 38. Global Blood Irradiation: by Application USD Million (2020-2025)
  • Figure 39. Global Blood Irradiation: by End User USD Million (2020-2025)
  • Figure 40. South America Blood Irradiation Share (%), by Country
  • Figure 41. Asia Pacific Blood Irradiation Share (%), by Country
  • Figure 42. Europe Blood Irradiation Share (%), by Country
  • Figure 43. MEA Blood Irradiation Share (%), by Country
  • Figure 44. North America Blood Irradiation Share (%), by Country
  • Figure 45. Global Blood Irradiation: by Type USD/Units (2020-2025)
Some of the key companies/manufacturers profiled in the report
  • Wuhan HNC Technology Co., Ltd. (China)
  • O3Vets (United States)
  • STS Steuerungstechnik + Strahlenchutz GmbH (Germany)
  • Best Theratronics (Canada)
  • Hitachi (Japan)
  • Gilardoni (Italy)
  • Gamma-Service Recycling GmbH (Germany)
  • Cegelec (France)
  • Rad Source Technologies (United States)
  • JL SHEPHERD & ASSOCIATES (United States)
Additional players considered in the study are as follows:
Shinva Medical (China) , NPIC (United States)
Select License Type
Sample Report Enquiry Before Buy Request Discount

Speak with Analyst

Want to find out more about this report?

Get Free Consultation